BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 20159943)

  • 1. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
    van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
    Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
    Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of a carboxy-terminal green fluorescent protein does not alter the binding and signaling properties of relaxin family Peptide receptor 3.
    van der Westhuizen ET; Wade JD; Sexton PM; Summers RJ
    Ann N Y Acad Sci; 2009 Apr; 1160():105-7. PubMed ID: 19416168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3.
    Summers RJ; Bathgate RA; Wade JD; van der Westhuizen ET; Halls ML
    Ann N Y Acad Sci; 2009 Apr; 1160():99-104. PubMed ID: 19416167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
    Halls ML; Bathgate RA; Summers RJ
    Mol Pharmacol; 2006 Jul; 70(1):214-26. PubMed ID: 16569707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
    Kocan M; Sarwar M; Hossain MA; Wade JD; Summers RJ
    Br J Pharmacol; 2014 Jun; 171(11):2827-41. PubMed ID: 24641548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of relaxin-related receptors by short, linear peptides derived from a collagen-containing precursor.
    Shemesh R; Hermesh C; Toporik A; Levine Z; Novik A; Wool A; Kliger Y; Rosenberg A; Bathgate RA; Cohen Y
    Ann N Y Acad Sci; 2009 Apr; 1160():78-86. PubMed ID: 19416163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes.
    Halls ML; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2007 Jan; 320(1):281-90. PubMed ID: 17065365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3.
    Haugaard-Kedström LM; Shabanpoor F; Hossain MA; Clark RJ; Ryan PJ; Craik DJ; Gundlach AL; Wade JD; Bathgate RA; Rosengren KJ
    J Am Chem Soc; 2011 Apr; 133(13):4965-74. PubMed ID: 21384867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
    Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
    Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
    Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
    Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
    J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors for relaxin family peptides.
    Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
    Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
    Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
    Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4.
    Ang SY; Hutchinson DS; Evans BA; Hossain MA; Patil N; Bathgate RA; Kocan M; Summers RJ
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):105-111. PubMed ID: 27888281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways of the LGR7 and LGR8 receptors determined by reporter genes.
    Halls ML; Bathgate RA; Roche PJ; Summers RJ
    Ann N Y Acad Sci; 2005 May; 1041():292-5. PubMed ID: 15956720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin family peptides and their receptors.
    Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
    Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
    Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
    Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.